Subscribe

Tema Oncology ETF (CANC)

USD40.94 -0.72 (-1.73%)
NASDAQ USD US Equity
NAV USD 35.65 +14.84% vs NAV as of 2026-02-02
AUM USD 142.24M
TER 0.75%
Yield (TTM) 0.05%
Distribution Distributing · Annual
52-week range 25.27 – 42.44
Holdings 58
Issuer Tema

About this ETF

The Tema Oncology ETF (CANC) seeks to invest in companies that potentially stand to benefit from further advances in oncology related biotechnology and healthcare.

ISIN US87975E7013
Issuer Tema
Domicile US
Inception 2023-08-14
Asset class Equity

Price

Top 10 holdings

REVOLUTION MEDICINES INC RVMD 6.00%
ELI LILLY & CO LLY 4.99%
COGENT BIOSCIENCES INC COGT 4.88%
NOVARTIS AG NOVN.SW 4.00%
ROCHE HOLDING AG RHHBY 3.82%
MERCK & CO INC MRK 3.40%
LEGEND BIOTECH CORP LEGN 3.39%
JOHNSON & JOHNSON JNJ 3.32%
IMMUNOME INC IMNM 3.26%
BRISTOL-MYERS SQUIBB CO BMY 3.23%
See full holdings →